John Carroll
Concepts (379)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carotid Body | 26 | 2015 | 46 | 7.940 |
Why?
| Chemoreceptor Cells | 14 | 2023 | 23 | 3.190 |
Why?
| Oocytes | 4 | 2022 | 94 | 2.520 |
Why?
| Potassium Channels, Tandem Pore Domain | 7 | 2015 | 11 | 2.340 |
Why?
| Hyperoxia | 8 | 2023 | 26 | 2.040 |
Why?
| Calcium | 9 | 2015 | 432 | 2.030 |
Why?
| Respiration, Artificial | 9 | 2023 | 285 | 1.620 |
Why?
| Oxygen | 10 | 2012 | 361 | 1.470 |
Why?
| Mitochondria | 6 | 2022 | 489 | 1.310 |
Why?
| Rats | 19 | 2015 | 3415 | 1.010 |
Why?
| Cell Hypoxia | 5 | 2013 | 87 | 1.000 |
Why?
| Membrane Potentials | 8 | 2015 | 139 | 0.990 |
Why?
| Respiration Disorders | 3 | 2023 | 25 | 0.980 |
Why?
| Animals, Newborn | 15 | 2015 | 396 | 0.960 |
Why?
| Embryonic Development | 1 | 2022 | 17 | 0.860 |
Why?
| Fertility | 1 | 2022 | 33 | 0.840 |
Why?
| Animals | 33 | 2022 | 14385 | 0.810 |
Why?
| Lung Diseases | 3 | 2019 | 86 | 0.800 |
Why?
| Nerve Tissue Proteins | 7 | 2015 | 199 | 0.760 |
Why?
| Hydrogen Peroxide | 1 | 2021 | 142 | 0.750 |
Why?
| Aortic Valve Stenosis | 4 | 2024 | 77 | 0.720 |
Why?
| Patch-Clamp Techniques | 7 | 2015 | 148 | 0.660 |
Why?
| Cystic Fibrosis | 3 | 2015 | 157 | 0.640 |
Why?
| Sleep Apnea Syndromes | 4 | 2023 | 31 | 0.630 |
Why?
| Home Care Services | 4 | 2023 | 79 | 0.610 |
Why?
| Rats, Sprague-Dawley | 10 | 2015 | 1663 | 0.610 |
Why?
| Sleep Apnea, Obstructive | 5 | 2018 | 65 | 0.600 |
Why?
| Infant, Premature | 7 | 2023 | 335 | 0.580 |
Why?
| Adenosine Triphosphate | 3 | 2013 | 242 | 0.580 |
Why?
| Tracheostomy | 2 | 2023 | 81 | 0.560 |
Why?
| Health Personnel | 2 | 2015 | 246 | 0.530 |
Why?
| Transient Receptor Potential Channels | 1 | 2015 | 3 | 0.520 |
Why?
| Hydrogen Sulfide | 1 | 2015 | 14 | 0.520 |
Why?
| Transition to Adult Care | 1 | 2015 | 13 | 0.520 |
Why?
| Humans | 53 | 2024 | 54284 | 0.520 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 88 | 0.510 |
Why?
| Respiratory Therapy | 1 | 2015 | 38 | 0.500 |
Why?
| AMP-Activated Protein Kinases | 1 | 2014 | 29 | 0.490 |
Why?
| Enzyme Inhibitors | 2 | 2014 | 446 | 0.480 |
Why?
| Electron Transport Complex IV | 1 | 2013 | 45 | 0.470 |
Why?
| Piperidines | 3 | 2021 | 103 | 0.460 |
Why?
| Child | 20 | 2020 | 7341 | 0.450 |
Why?
| Pediatrics | 2 | 2016 | 323 | 0.450 |
Why?
| Sleep | 5 | 2021 | 188 | 0.440 |
Why?
| Staphylococcal Infections | 1 | 2015 | 300 | 0.430 |
Why?
| Neural Conduction | 3 | 2009 | 45 | 0.430 |
Why?
| Clinical Competence | 1 | 2015 | 446 | 0.420 |
Why?
| Bronchopulmonary Dysplasia | 3 | 2023 | 69 | 0.410 |
Why?
| Analysis of Variance | 6 | 2015 | 635 | 0.410 |
Why?
| Potassium Channels, Inwardly Rectifying | 1 | 2011 | 6 | 0.400 |
Why?
| Osteogenesis Imperfecta | 2 | 2022 | 39 | 0.400 |
Why?
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2011 | 13 | 0.390 |
Why?
| Female | 32 | 2023 | 28441 | 0.390 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 543 | 0.390 |
Why?
| Collagen Type I | 2 | 2022 | 97 | 0.380 |
Why?
| Mechanotransduction, Cellular | 1 | 2011 | 35 | 0.380 |
Why?
| Pulmonary Ventilation | 1 | 2010 | 22 | 0.380 |
Why?
| Infant | 15 | 2023 | 3817 | 0.360 |
Why?
| Aging | 3 | 2004 | 784 | 0.350 |
Why?
| Signal Transduction | 2 | 2005 | 1753 | 0.320 |
Why?
| Infant, Newborn | 12 | 2023 | 2907 | 0.320 |
Why?
| Receptors, Dopamine D2 | 2 | 2005 | 17 | 0.320 |
Why?
| Male | 27 | 2022 | 27334 | 0.290 |
Why?
| Neurotransmitter Agents | 2 | 2009 | 38 | 0.290 |
Why?
| Infant, Extremely Premature | 2 | 2023 | 31 | 0.290 |
Why?
| Chronic Disease | 5 | 2019 | 614 | 0.290 |
Why?
| Sleep Stages | 3 | 2011 | 46 | 0.280 |
Why?
| Polysomnography | 8 | 2015 | 71 | 0.270 |
Why?
| Registries | 5 | 2024 | 553 | 0.270 |
Why?
| Respiration | 5 | 2023 | 99 | 0.270 |
Why?
| Time Factors | 7 | 2022 | 3213 | 0.270 |
Why?
| Delivery of Health Care | 2 | 2019 | 327 | 0.270 |
Why?
| United States | 10 | 2024 | 5217 | 0.270 |
Why?
| Continuous Positive Airway Pressure | 2 | 2018 | 58 | 0.270 |
Why?
| Pregnancy | 5 | 2022 | 2620 | 0.260 |
Why?
| Patient Discharge | 2 | 2019 | 353 | 0.260 |
Why?
| Infant, Premature, Diseases | 2 | 2023 | 91 | 0.260 |
Why?
| Hospitals, Pediatric | 3 | 2015 | 272 | 0.260 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2004 | 14 | 0.260 |
Why?
| Potassium | 1 | 2004 | 60 | 0.250 |
Why?
| Age Factors | 5 | 2019 | 1198 | 0.240 |
Why?
| Oximes | 2 | 2021 | 12 | 0.230 |
Why?
| Pyridines | 1 | 2004 | 137 | 0.230 |
Why?
| Sleep Apnea, Central | 1 | 2003 | 9 | 0.230 |
Why?
| Reactive Oxygen Species | 2 | 2022 | 491 | 0.230 |
Why?
| Cells, Cultured | 4 | 2020 | 1737 | 0.230 |
Why?
| Respiratory Muscles | 1 | 2003 | 6 | 0.230 |
Why?
| Movement | 2 | 2021 | 111 | 0.220 |
Why?
| Respiratory System | 1 | 2003 | 28 | 0.220 |
Why?
| Dynamins | 1 | 2022 | 6 | 0.220 |
Why?
| Neuronal Plasticity | 1 | 2003 | 58 | 0.220 |
Why?
| DNA, Mitochondrial | 2 | 2022 | 186 | 0.210 |
Why?
| Ehlers-Danlos Syndrome | 1 | 2022 | 6 | 0.210 |
Why?
| Oogenesis | 1 | 2022 | 17 | 0.210 |
Why?
| Cytoplasm | 1 | 2022 | 108 | 0.210 |
Why?
| Intracellular Space | 2 | 2014 | 31 | 0.210 |
Why?
| Catecholamines | 2 | 2013 | 48 | 0.210 |
Why?
| In Vitro Oocyte Maturation Techniques | 1 | 2021 | 1 | 0.200 |
Why?
| Dose-Response Relationship, Drug | 3 | 2015 | 1476 | 0.200 |
Why?
| Australia | 1 | 2021 | 85 | 0.190 |
Why?
| Risk Factors | 9 | 2024 | 3935 | 0.190 |
Why?
| Electrophysiology | 2 | 2011 | 76 | 0.190 |
Why?
| Ventilators, Mechanical | 1 | 2020 | 42 | 0.180 |
Why?
| Prisoners | 1 | 2021 | 84 | 0.180 |
Why?
| Posture | 1 | 2020 | 80 | 0.180 |
Why?
| Respiratory Mechanics | 2 | 2018 | 38 | 0.180 |
Why?
| Extracellular Matrix Proteins | 1 | 2020 | 75 | 0.180 |
Why?
| Molecular Chaperones | 1 | 2020 | 64 | 0.180 |
Why?
| Action Potentials | 2 | 2013 | 131 | 0.170 |
Why?
| Mice | 5 | 2022 | 6413 | 0.170 |
Why?
| Tertiary Care Centers | 2 | 2018 | 83 | 0.170 |
Why?
| RNA, Messenger | 4 | 2011 | 1202 | 0.170 |
Why?
| Plethysmography | 1 | 2018 | 45 | 0.170 |
Why?
| Ion Channel Gating | 2 | 2011 | 47 | 0.160 |
Why?
| Nitric Oxide | 2 | 2011 | 298 | 0.160 |
Why?
| Child, Preschool | 8 | 2018 | 4147 | 0.160 |
Why?
| Membrane Potential, Mitochondrial | 2 | 2015 | 48 | 0.160 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2011 | 151 | 0.160 |
Why?
| Spirometry | 1 | 2018 | 30 | 0.160 |
Why?
| Disease Models, Animal | 4 | 2022 | 1639 | 0.160 |
Why?
| Adolescent | 10 | 2018 | 6897 | 0.150 |
Why?
| Aortic Valve | 3 | 2024 | 113 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 673 | 0.150 |
Why?
| KCNQ2 Potassium Channel | 1 | 2017 | 18 | 0.150 |
Why?
| Myoclonus | 1 | 2017 | 10 | 0.150 |
Why?
| Opioid-Related Disorders | 1 | 2021 | 367 | 0.140 |
Why?
| Spasms, Infantile | 1 | 2017 | 30 | 0.140 |
Why?
| Hospitals, Special | 1 | 2016 | 9 | 0.140 |
Why?
| Obesity | 2 | 2015 | 1202 | 0.140 |
Why?
| Molecular Typing | 1 | 2015 | 10 | 0.140 |
Why?
| Length of Stay | 1 | 2019 | 683 | 0.140 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 28 | 0.140 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2017 | 552 | 0.140 |
Why?
| Patient Care Team | 2 | 2015 | 273 | 0.140 |
Why?
| Coinfection | 1 | 2015 | 34 | 0.140 |
Why?
| Pseudomonas Infections | 1 | 2015 | 54 | 0.130 |
Why?
| Arteries | 2 | 2009 | 101 | 0.130 |
Why?
| Alkynes | 1 | 2015 | 5 | 0.130 |
Why?
| Manikins | 1 | 2015 | 40 | 0.130 |
Why?
| Sodium Compounds | 1 | 2015 | 6 | 0.130 |
Why?
| Intracellular Fluid | 1 | 2015 | 15 | 0.130 |
Why?
| Pseudomonas aeruginosa | 1 | 2015 | 86 | 0.130 |
Why?
| DNA, Bacterial | 1 | 2015 | 172 | 0.130 |
Why?
| Boron Compounds | 1 | 2015 | 18 | 0.130 |
Why?
| NAD | 1 | 2015 | 46 | 0.130 |
Why?
| Glycine | 1 | 2015 | 70 | 0.130 |
Why?
| Risk Assessment | 3 | 2015 | 1361 | 0.130 |
Why?
| Patient Safety | 1 | 2015 | 121 | 0.130 |
Why?
| Tacrolimus | 1 | 2015 | 52 | 0.130 |
Why?
| Retrospective Studies | 6 | 2020 | 6432 | 0.130 |
Why?
| RNA | 2 | 2006 | 202 | 0.130 |
Why?
| Computer Simulation | 1 | 2015 | 332 | 0.120 |
Why?
| Aminoimidazole Carboxamide | 1 | 2014 | 3 | 0.120 |
Why?
| Ribonucleotides | 1 | 2014 | 5 | 0.120 |
Why?
| Pyrones | 1 | 2014 | 8 | 0.120 |
Why?
| Enzyme Activators | 1 | 2014 | 8 | 0.120 |
Why?
| Foreign Bodies | 1 | 2015 | 64 | 0.120 |
Why?
| PC12 Cells | 1 | 2014 | 31 | 0.120 |
Why?
| Disease Management | 1 | 2015 | 184 | 0.120 |
Why?
| Biphenyl Compounds | 1 | 2014 | 30 | 0.120 |
Why?
| Genotype | 1 | 2015 | 599 | 0.120 |
Why?
| Polymerase Chain Reaction | 1 | 2015 | 531 | 0.120 |
Why?
| Reference Values | 3 | 2011 | 354 | 0.120 |
Why?
| Sodium Cyanide | 1 | 2013 | 2 | 0.120 |
Why?
| Forced Expiratory Volume | 1 | 2014 | 46 | 0.120 |
Why?
| Thiophenes | 1 | 2014 | 37 | 0.120 |
Why?
| Mutation | 3 | 2022 | 1501 | 0.120 |
Why?
| Treatment Outcome | 6 | 2024 | 5604 | 0.120 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 2011 | 53 | 0.120 |
Why?
| Aged | 3 | 2022 | 10054 | 0.110 |
Why?
| Rural Population | 1 | 2018 | 600 | 0.110 |
Why?
| Quality of Health Care | 1 | 2015 | 222 | 0.110 |
Why?
| Cardiac Catheterization | 1 | 2015 | 258 | 0.110 |
Why?
| Colostomy | 1 | 2012 | 10 | 0.110 |
Why?
| Referral and Consultation | 1 | 2015 | 307 | 0.110 |
Why?
| Pediatric Nursing | 1 | 2012 | 15 | 0.110 |
Why?
| Patient Advocacy | 1 | 2012 | 23 | 0.110 |
Why?
| Prevalence | 1 | 2015 | 1025 | 0.110 |
Why?
| Administration, Intravenous | 1 | 2012 | 75 | 0.110 |
Why?
| Receptors, Purinergic P2Y12 | 1 | 2012 | 13 | 0.110 |
Why?
| Phosphorylation | 1 | 2014 | 614 | 0.110 |
Why?
| Multicenter Studies as Topic | 2 | 2022 | 91 | 0.110 |
Why?
| Narcolepsy | 1 | 2011 | 11 | 0.100 |
Why?
| Nocturnal Myoclonus Syndrome | 1 | 2011 | 14 | 0.100 |
Why?
| Receptors, Purinergic P2 | 1 | 2012 | 37 | 0.100 |
Why?
| Patient Compliance | 1 | 2013 | 249 | 0.100 |
Why?
| Telemedicine | 1 | 2018 | 449 | 0.100 |
Why?
| Respiratory Physiological Phenomena | 2 | 2019 | 9 | 0.100 |
Why?
| Disabled Children | 1 | 2012 | 73 | 0.100 |
Why?
| Cyanides | 1 | 2011 | 4 | 0.100 |
Why?
| Glyburide | 1 | 2011 | 6 | 0.100 |
Why?
| Receptors, Drug | 1 | 2011 | 6 | 0.100 |
Why?
| Diazoxide | 1 | 2011 | 6 | 0.100 |
Why?
| Biophysics | 1 | 2011 | 20 | 0.100 |
Why?
| KATP Channels | 1 | 2011 | 6 | 0.100 |
Why?
| Sweetening Agents | 1 | 2011 | 24 | 0.100 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2011 | 31 | 0.100 |
Why?
| Supine Position | 2 | 2021 | 33 | 0.100 |
Why?
| Electric Stimulation | 1 | 2011 | 95 | 0.100 |
Why?
| Prone Position | 2 | 2021 | 38 | 0.100 |
Why?
| Ataxia Telangiectasia | 1 | 2010 | 5 | 0.100 |
Why?
| Bronchiectasis | 1 | 2010 | 10 | 0.100 |
Why?
| Rubinstein-Taybi Syndrome | 1 | 2010 | 3 | 0.090 |
Why?
| Vasodilator Agents | 1 | 2011 | 111 | 0.090 |
Why?
| Lung Diseases, Interstitial | 1 | 2010 | 22 | 0.090 |
Why?
| Medicare | 2 | 2022 | 241 | 0.090 |
Why?
| Electromyography | 2 | 2021 | 150 | 0.090 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2010 | 35 | 0.090 |
Why?
| Deglutition Disorders | 2 | 2010 | 71 | 0.090 |
Why?
| Carbon Dioxide | 1 | 2010 | 102 | 0.090 |
Why?
| Bronchodilator Agents | 1 | 2010 | 74 | 0.090 |
Why?
| Glossopharyngeal Nerve | 1 | 2009 | 2 | 0.090 |
Why?
| Potassium Chloride | 1 | 2009 | 18 | 0.090 |
Why?
| Arkansas | 1 | 2016 | 2100 | 0.090 |
Why?
| Ruthenium Red | 1 | 2009 | 4 | 0.090 |
Why?
| Hypoglycemic Agents | 1 | 2011 | 177 | 0.090 |
Why?
| Isomerism | 1 | 2009 | 24 | 0.090 |
Why?
| Potassium Channel Blockers | 1 | 2009 | 18 | 0.090 |
Why?
| Blood Pressure | 3 | 2005 | 587 | 0.090 |
Why?
| Arachidonic Acids | 1 | 2009 | 26 | 0.090 |
Why?
| Crohn Disease | 1 | 2010 | 96 | 0.090 |
Why?
| Magnesium | 1 | 2009 | 42 | 0.090 |
Why?
| Coloring Agents | 1 | 2009 | 84 | 0.090 |
Why?
| Lung | 2 | 2022 | 507 | 0.080 |
Why?
| Glucose | 1 | 2011 | 366 | 0.080 |
Why?
| HeLa Cells | 1 | 2009 | 291 | 0.080 |
Why?
| Prospective Studies | 3 | 2023 | 2604 | 0.070 |
Why?
| Gene Expression Regulation | 1 | 2012 | 1062 | 0.070 |
Why?
| Diagnosis, Differential | 2 | 2015 | 1136 | 0.070 |
Why?
| Parents | 2 | 2012 | 344 | 0.070 |
Why?
| Quinpirole | 1 | 2005 | 2 | 0.070 |
Why?
| Sulpiride | 1 | 2005 | 3 | 0.070 |
Why?
| Mountaineering | 1 | 2005 | 3 | 0.070 |
Why?
| Dopamine Agonists | 1 | 2005 | 9 | 0.070 |
Why?
| Dopamine Antagonists | 1 | 2005 | 19 | 0.070 |
Why?
| Acclimatization | 1 | 2005 | 17 | 0.060 |
Why?
| Medulla Oblongata | 2 | 1995 | 12 | 0.060 |
Why?
| Fetal Diseases | 1 | 2005 | 54 | 0.060 |
Why?
| Follow-Up Studies | 4 | 2015 | 2387 | 0.060 |
Why?
| Ventricular Dysfunction, Left | 1 | 2005 | 98 | 0.060 |
Why?
| Apnea | 1 | 2023 | 20 | 0.060 |
Why?
| Medical History Taking | 1 | 2004 | 51 | 0.060 |
Why?
| Oxygen Consumption | 1 | 2005 | 223 | 0.060 |
Why?
| Circadian Rhythm | 1 | 2004 | 85 | 0.060 |
Why?
| Bradycardia | 1 | 2023 | 35 | 0.060 |
Why?
| Snoring | 1 | 2003 | 10 | 0.060 |
Why?
| Physical Examination | 1 | 2004 | 99 | 0.060 |
Why?
| Receptors, Dopamine D1 | 1 | 2003 | 11 | 0.060 |
Why?
| Reflex | 1 | 2003 | 33 | 0.060 |
Why?
| Gene Expression | 1 | 2006 | 664 | 0.060 |
Why?
| International Cooperation | 1 | 2003 | 63 | 0.060 |
Why?
| Nervous System | 1 | 2003 | 34 | 0.060 |
Why?
| X-Ray Microtomography | 1 | 2022 | 82 | 0.050 |
Why?
| Collagen Type V | 1 | 2022 | 4 | 0.050 |
Why?
| Hospitals | 1 | 2024 | 188 | 0.050 |
Why?
| Haploinsufficiency | 1 | 2022 | 13 | 0.050 |
Why?
| Respiratory Function Tests | 2 | 2014 | 98 | 0.050 |
Why?
| Pharynx | 2 | 2015 | 39 | 0.050 |
Why?
| Adult | 2 | 2015 | 14207 | 0.050 |
Why?
| Fetus | 1 | 2003 | 227 | 0.050 |
Why?
| Injections, Intramuscular | 1 | 2021 | 50 | 0.050 |
Why?
| Delayed-Action Preparations | 1 | 2021 | 50 | 0.050 |
Why?
| Prisons | 1 | 2021 | 35 | 0.050 |
Why?
| Naltrexone | 1 | 2021 | 62 | 0.050 |
Why?
| Collagen | 1 | 2022 | 223 | 0.050 |
Why?
| Administration, Inhalation | 2 | 2011 | 119 | 0.050 |
Why?
| Ventilator Weaning | 1 | 2020 | 24 | 0.050 |
Why?
| Incidence | 2 | 2015 | 1082 | 0.050 |
Why?
| Narcotic Antagonists | 1 | 2021 | 127 | 0.050 |
Why?
| Oxidative Stress | 1 | 2005 | 958 | 0.040 |
Why?
| Intensive Care Units | 1 | 2020 | 231 | 0.040 |
Why?
| Protein Processing, Post-Translational | 1 | 2020 | 183 | 0.040 |
Why?
| Clinical Protocols | 1 | 2019 | 122 | 0.040 |
Why?
| Monitoring, Physiologic | 1 | 2019 | 136 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2011 | 232 | 0.040 |
Why?
| Histidine | 1 | 2017 | 17 | 0.040 |
Why?
| Mice, Knockout | 1 | 2020 | 926 | 0.040 |
Why?
| Community Health Services | 1 | 2018 | 115 | 0.040 |
Why?
| Cysteine | 1 | 2017 | 62 | 0.040 |
Why?
| Quality Assurance, Health Care | 1 | 2018 | 164 | 0.040 |
Why?
| Research Design | 1 | 2019 | 374 | 0.040 |
Why?
| Societies | 1 | 2016 | 5 | 0.040 |
Why?
| Models, Statistical | 1 | 2018 | 259 | 0.040 |
Why?
| Analgesics, Opioid | 1 | 2021 | 501 | 0.030 |
Why?
| Pilot Projects | 1 | 2018 | 808 | 0.030 |
Why?
| Anticonvulsants | 1 | 2017 | 129 | 0.030 |
Why?
| Quality Improvement | 1 | 2018 | 245 | 0.030 |
Why?
| Uvula | 1 | 2015 | 9 | 0.030 |
Why?
| Palate | 1 | 2015 | 14 | 0.030 |
Why?
| Arginine | 1 | 2017 | 182 | 0.030 |
Why?
| Cinnamates | 1 | 2015 | 3 | 0.030 |
Why?
| Bronchography | 1 | 2015 | 6 | 0.030 |
Why?
| Thiourea | 1 | 2015 | 11 | 0.030 |
Why?
| Adenoidectomy | 1 | 2015 | 34 | 0.030 |
Why?
| Afferent Pathways | 1 | 1994 | 8 | 0.030 |
Why?
| Tonsillectomy | 1 | 2015 | 49 | 0.030 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2015 | 42 | 0.030 |
Why?
| Hypoxia, Brain | 1 | 1994 | 15 | 0.030 |
Why?
| Bronchi | 1 | 2015 | 51 | 0.030 |
Why?
| Respiratory Sounds | 1 | 2015 | 54 | 0.030 |
Why?
| Cough | 1 | 2015 | 55 | 0.030 |
Why?
| Electroencephalography | 1 | 2017 | 356 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2011 | 1084 | 0.030 |
Why?
| Bronchoscopy | 1 | 2015 | 79 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2020 | 1999 | 0.030 |
Why?
| Phenotype | 1 | 2017 | 820 | 0.030 |
Why?
| Caregivers | 1 | 2016 | 241 | 0.030 |
Why?
| Staff Development | 1 | 2013 | 26 | 0.030 |
Why?
| Professional-Patient Relations | 1 | 2013 | 52 | 0.030 |
Why?
| Seizures | 1 | 2015 | 208 | 0.030 |
Why?
| Professional Role | 1 | 2013 | 88 | 0.030 |
Why?
| Survival Rate | 1 | 2015 | 951 | 0.030 |
Why?
| Ambulatory Care Facilities | 1 | 2013 | 136 | 0.030 |
Why?
| Social Isolation | 1 | 2012 | 29 | 0.030 |
Why?
| Professional-Family Relations | 1 | 2012 | 49 | 0.030 |
Why?
| Sleep, REM | 1 | 2011 | 51 | 0.030 |
Why?
| Immunohistochemistry | 1 | 2015 | 1089 | 0.030 |
Why?
| Sex Distribution | 1 | 2011 | 158 | 0.030 |
Why?
| Age Distribution | 1 | 2011 | 198 | 0.030 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2011 | 6 | 0.030 |
Why?
| Ambulatory Care | 1 | 2013 | 230 | 0.030 |
Why?
| Potassium Channels | 1 | 2011 | 41 | 0.020 |
Why?
| Schools | 1 | 2012 | 176 | 0.020 |
Why?
| Emotions | 1 | 2012 | 168 | 0.020 |
Why?
| Calcium Signaling | 1 | 2011 | 59 | 0.020 |
Why?
| Patient Education as Topic | 1 | 2013 | 313 | 0.020 |
Why?
| Social Support | 1 | 2012 | 299 | 0.020 |
Why?
| Stress, Psychological | 1 | 2012 | 270 | 0.020 |
Why?
| Comorbidity | 1 | 2011 | 663 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2017 | 1604 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2010 | 281 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2015 | 1213 | 0.020 |
Why?
| Gene Deletion | 1 | 2010 | 293 | 0.020 |
Why?
| Case-Control Studies | 1 | 2011 | 1228 | 0.020 |
Why?
| Prognosis | 1 | 2014 | 2118 | 0.020 |
Why?
| Postoperative Complications | 1 | 2015 | 1033 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2010 | 490 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2011 | 596 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2015 | 3431 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2010 | 492 | 0.020 |
Why?
| Barium Sulfate | 1 | 2006 | 13 | 0.020 |
Why?
| Respiratory Aspiration | 1 | 2006 | 9 | 0.020 |
Why?
| Fluoroscopy | 1 | 2006 | 45 | 0.020 |
Why?
| Video Recording | 1 | 2006 | 90 | 0.020 |
Why?
| Cardiac Volume | 1 | 2005 | 7 | 0.020 |
Why?
| Carotid Sinus | 2 | 1995 | 6 | 0.020 |
Why?
| Diastole | 1 | 2005 | 79 | 0.020 |
Why?
| Denervation | 2 | 1995 | 21 | 0.020 |
Why?
| Contrast Media | 1 | 2006 | 221 | 0.020 |
Why?
| Systole | 1 | 2005 | 80 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2005 | 114 | 0.020 |
Why?
| Cats | 2 | 1995 | 52 | 0.020 |
Why?
| Myocardial Contraction | 1 | 2005 | 116 | 0.020 |
Why?
| Mitral Valve | 1 | 2005 | 70 | 0.020 |
Why?
| Oxyhemoglobins | 1 | 2004 | 6 | 0.020 |
Why?
| Blood Gas Analysis | 1 | 2004 | 32 | 0.020 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 40 | 0.020 |
Why?
| Ventricular Function, Left | 1 | 2005 | 181 | 0.010 |
Why?
| Arousal | 1 | 2004 | 106 | 0.010 |
Why?
| Ganglia, Sensory | 1 | 2003 | 1 | 0.010 |
Why?
| Superior Cervical Ganglion | 1 | 2003 | 7 | 0.010 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2003 | 83 | 0.010 |
Why?
| International Classification of Diseases | 1 | 2003 | 65 | 0.010 |
Why?
| Corpus Striatum | 1 | 2003 | 66 | 0.010 |
Why?
| Echocardiography | 1 | 2005 | 392 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2003 | 401 | 0.010 |
Why?
| Rabbits | 1 | 2003 | 425 | 0.010 |
Why?
| Young Adult | 1 | 2011 | 4318 | 0.010 |
Why?
| Body Mass Index | 1 | 2004 | 713 | 0.010 |
Why?
| Heart Failure | 1 | 2005 | 541 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2002 | 1304 | 0.010 |
Why?
| Vagotomy | 1 | 1995 | 7 | 0.010 |
Why?
| Nitroprusside | 1 | 1995 | 12 | 0.010 |
Why?
| Phenylephrine | 1 | 1995 | 34 | 0.010 |
Why?
| Optics and Photonics | 1 | 1995 | 13 | 0.010 |
Why?
| Light | 1 | 1995 | 82 | 0.010 |
Why?
| Tidal Volume | 1 | 1994 | 55 | 0.010 |
Why?
| Cerebral Cortex | 1 | 1995 | 234 | 0.010 |
Why?
| Electrocardiography | 1 | 1994 | 290 | 0.010 |
Why?
|
|
Carroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|